Jubilant Pharmova has informed that it enclosed a communication pursuant to Provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company has received communication from USFDA at 01:44 am (IST) on July 19, 2024. The above mentioned document will be simultaneously posted on the Company's website at www.jubilantpharmova.com.
The above information is a part of company’s filings submitted to BSE.